Changes in membrane properties during energy depletion-induced cell injury studied with fluorescence microscopy.
The changes in membrane structural properties occurring during the process of ATP depletion-induced cell injury in adherent human astrocytoma cells (UC-11 MG) were studied with two epifluorescence techniques: 1) steady-state fluorescence anisotropy (r) to examine microstructural changes in the membrane phospholipids and 2) fluorescence redistribution after photobleaching (FRAP) to examine membrane fluidity changes. A new method for r measurement was established that provides the unique advantage of simultaneously monitoring both vertical and horizontal polarized fluorescence emissions needed for the calculation of r. In this study, r in the astrocytoma cells labeled with 1-(4-trimethylammonium phenyl)-6-phenyl-1,3,5-hexatriene p-toluenesulfonate was shown to remain stable for up to 90 min. However, when the cells were treated with 75 microM iodoacetic acid (IAA), a metabolic inhibitor that induces rapid depletion of cellular ATP, r continually decreased, indicating a decrease in membrane lipid order and perturbation of the bilayer structure. This decrease in r could be prevented by the pretreatment of cells with lipophilic antioxidants such as tirilazad or gossypol. Tirilazad itself caused a significant increase in r, suggesting that tirilazad intercalates into the membrane bilayer and profoundly increases the lipid order in uninjured cells. Gossypol, however, did not exhibit this property. Further investigations into these phenomena with FRAP confirmed the r results and indicated that membrane fluidity increased while its structure became less rigid during the process of ATP-induced cell injury. In addition, lipophilic antioxidants prevented the membrane structural aberrations induced by IAA. Experimental results suggest that different mechanisms of cytoprotective action may exist for tirilazad and the antioxidant gossypol. Gossypol appears to prevent or delay the observed cell injury entirely because of its antioxidant action, whereas tirilazad's protection is mediated not only via its antioxidant activity, but also by its ability to increase cell membrane lipid order.
Wu
Y
Y
Pharmacia and Upjohn, Kalamazoo, Michigan 49001, USA.
Sun
F F
FF
Tong
D M
DM
Taylor
B M
BM
D000255:Adenosine Triphosphate / Q000378:metabolism*; D000963:Antimetabolites / Q000494:pharmacology; D000975:Antioxidants / Q000494:pharmacology; D001254:Astrocytoma / Q000378:metabolism; D055592:Biophysical Phenomena; D001703:Biophysics; D002448:Cell Adhesion; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism*; D002470:Cell Survival; D004161:Diphenylhexatriene / Q000031:analogs & derivatives; D004734:Energy Metabolism; D005454:Fluorescence Polarization; D005456:Fluorescent Dyes; D006072:Gossypol / Q000494:pharmacology; D006801:Humans; D007461:Iodoacetates / Q000494:pharmacology; D019807:Iodoacetic Acid; D008560:Membrane Fluidity; D008563:Membrane Lipids / Q000378:metabolism; D008856:Microscopy, Fluorescence; D011281:Pregnatrienes / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D000963:Antimetabolites; D000975:Antioxidants; D005456:Fluorescent Dyes; D007461:Iodoacetates; D008563:Membrane Lipids; D011281:Pregnatrienes; D004161:Diphenylhexatriene; C033628:1-(4-(trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene; D000255:Adenosine Triphosphate; D006072:Gossypol; D019807:Iodoacetic Acid; C053355:tirilazad